Zannes Maria - Insider Non-Derivative Transactions at bioAffinity Technologies, Inc. (BIAF) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Jan 10, 2025, Zannes Maria's relationship to bioAffinity Technologies, Inc. (BIAF) is Director,Officer (President & CEO), and currently has 280,359 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other BIAF insiders.

Related Topics: SEC Topic List.
Data Source: SEC.
Zannes Maria - Insider Non-Derivative Transactions of BIAF Common Stock
Zannes Maria - Insider Non-Derivative Transactions at BIAF
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Jan 11, 2025 Acquisition -- (Common Stock) 37037 0 280359
Jul 2, 2024 Acquisition -- (Common Stock) 33784 0 243322
Jun 13, 2024 Acquisition -- (Common Stock) 8296 0 209538
Apr 9, 2024 F -- (Common Stock) 28264 2.65 201242
Apr 9, 2024 M -- (Common Stock) 64848 1.16 229506
Feb 1, 2024 Acquisition -- (Common Stock) 23885 0 164658
Jan 2, 2024 Acquisition -- (Common Stock) 12668 1.48 140773
Oct 2, 2023 Acquisition -- (Common Stock) 11867 1.58 128105
Jul 2, 2023 Acquisition -- (Common Stock) 10245 1.83 116238
Jun 7, 2023 Acquisition -- (Common Stock) 26178 1.91 105993
Apr 16, 2023 Acquisition -- (Common Stock) 9920 1.89 79815
Jan 2, 2023 Acquisition -- (Common Stock) 8227 2.28 69895